W., et al., Gastrointestinal Adverse Events and Weight Reduction in People With Type 2 Diabetes Treated With Tirzepatide in the SURPASS Clinical Trials, Diabetes, Obesity and Metabolism 26, no
This could involve adding another medication to your treatment plan, such as insulin or a different type of diabetes medication
[] In this study, another relationship was also established between Hb level and ferritin level and the increased severity of COVID-19 infection
In: De Simone C, Martelli EA (eds) Stress, Immunity and AgeingA Role for Acetyl L carnitine Excerpta Medica: Amsterdam 1989
Wegovy has the deeper long-term outcome data, especially the SELECT trial, which shows cardiovascular event reduction in patients with established cardiovascular disease and overweight or obesity
I was an advisor to Novo Nordisk on the phase two trials, and we were so afraid of the side effects that we advised them to use doses that were too small